Abstract：
:Seizures are a relatively common occurrence in patients with HIV infection. They may be a result of HIV infection of the CNS or a manifestation of an opportunistic infection. Because seizures are likely to recur in patients infected with HIV and because they are a poor prognostic indicator, it is generally recommended that all HIV-seropositive patients experiencing a first seizure without a recognisable and reversible cause be treated. Clinicians faced with treating seizures in HIV-seropositive patients often encounter a therapeutic dilemma since few data exist in this area. In selecting appropriate anticonvulsant therapy, clinicians must consider both therapy-compromising drug-drug and drug-disease interactions. Ideal anticonvulsants for this setting are those that do not effect viral replication, have limited protein binding and have no effects on the cytochrome P450 system, such as gabapentin, topiramate and tiagabine. Unless the benefits outweigh the risks, valproic acid (sodium valproate) should be avoided as it has been shown to stimulate HIV replication. Since few data exist, controlled trials examining pharmacokinetic and pharmacodynamic interactions between anticonvulsants and antiretrovirals are needed. Until such time, clinicians caring for these patients should examine existing data carefully and employ vigilant monitoring.
journal_name
CNS Drugsjournal_title
CNS drugsauthors
Romanelli F,Ryan Mdoi
10.2165/00023210-200216020-00002subject
Has Abstractpub_date
2002-01-01 00:00:00pages
91-8issue
2eissn
1172-7047issn
1179-1934pii
160202journal_volume
16pub_type
杂志文章,评审相关文献
CNS DRUGS文献大全abstract：:Dravet syndrome (DS) is a medically refractory epilepsy that onsets in the first year of life with prolonged seizures, often triggered by fever. Over time, patients develop other seizure types (myoclonic, atypical absences, drops), intellectual disability, crouch gait and other co-morbidities (sleep problems, autonomi...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.1007/s40263-018-0511-y
更新日期：2018-04-01 00:00:00
abstract：:The almost ubiquitous sleep disturbances in patients with depression commonly, but not always, subside with the remission of depression. Evidence linking insomnia with the risk of relapses in recurrent depression, as well as suicide, makes optimization of the treatment of insomnia associated with depression a priority...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.2165/00023210-200923040-00004
更新日期：2009-01-01 00:00:00
abstract：:Statins, or 3-hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, such as lovastatin, atorvastatin, simvastatin, pravastatin, fluvastatin, rosuvastatin and pitavastatin, are cholesterol-lowering drugs used in clinical practice to prevent coronary heart disease. These drugs are generally well tolerated and have ...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.1007/s40263-013-0135-1
更新日期：2014-03-01 00:00:00
abstract：:Anticonvulsant hypersensitivity syndrome (AHS) is a rare, but potentially fatal, adverse reaction that occurs in patients, including children, who are treated with anticonvulsants. During metabolism of the anticonvulsant, toxic arene-oxide compounds are produced. AHS is associated with both cutaneous and systemic symp...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.2165/00023210-200216030-00006
更新日期：2002-01-01 00:00:00
abstract：OBJECTIVE:To determine the efficacy and tolerability of zolmitriptan 2.5 mg oral tablet as an acute treatment for menstrual migraine attacks. METHODS:This was a two-phase, multicentre, randomised, double-blind, placebo-controlled, parallel-group outpatient study (Phase I is reported here). The study was conducted at 2...
journal_title：CNS drugs
pub_type： 杂志文章,多中心研究,随机对照试验
doi：10.2165/00023210-200620120-00005
更新日期：2006-01-01 00:00:00
abstract：:Subacute sclerosing panencephalitis (SSPE) is a chronic progressive, usually fatal disease of uncertain pathogenesis that is associated with the presence of mutant measles virus in the CNS. The diagnosis is based on clinical criteria and an elevated titre of measles antibodies in the CSF. Electroencephalography, imagi...
journal_title：CNS drugs
pub_type： 杂志文章
doi：10.2165/00023210-199707020-00003
更新日期：1997-02-01 00:00:00
abstract：:A wide range of support is available to help smokers to quit and to aid attempts at harm reduction, including three first-line smoking cessation medications: nicotine replacement therapy, varenicline and bupropion. Despite the efficacy of these, there is a continual need to diversify the range of medications so that t...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.1007/s40263-016-0362-3
更新日期：2016-10-01 00:00:00
abstract：:Lisdexamfetamine dimesylate (lisdexamfetamine) is a long-acting amfetamine prodrug with a convenient once-daily oral regimen that offers the potential for improved adherence and reduced abuse compared with short-acting preparations of amfetamines. Lisdexamfetamine (as Elvanse Adult(®); Tyvense Adult™) has been approve...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.1007/s40263-016-0327-6
更新日期：2016-04-01 00:00:00
abstract：BACKGROUND:No head-to-head clinical trials have been published comparing guanfacine extended release (GXR) and atomoxetine (ATX): two nonstimulants approved for the treatment of attention-deficit/hyperactivity disorder (ADHD). However, other study designs or methods could be used to indirectly compare these two medicat...
journal_title：CNS drugs
pub_type： 杂志文章
doi：10.1007/s40263-013-0102-x
更新日期：2013-11-01 00:00:00
abstract：:The neuronal ceroid lipofuscinoses comprise a group of neurodegenerative lysosomal storage disorders caused by mutations in at least 13 different genes and primarily affect the brain and the retina of children or young adults. The disorders are characterized by progressive neurological deterioration with dementia, epi...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.1007/s40263-019-00620-8
更新日期：2019-04-01 00:00:00
abstract：:Teriflunomide is a once-daily oral agent that has been licensed in the EU since August 2013 for the treatment of adult patients with relapsing-remitting multiple sclerosis (RRMS). More recently (September 2014), the EU summary of product characteristics (SmPC) was updated to include data from patients with a first cli...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.1007/s40263-015-0299-y
更新日期：2016-01-01 00:00:00
abstract：:Pregabalin, the pharmacologically active S-enantiomer of 3-aminomethyl-5-methylhexanoic acid, possesses anticonvulsant activity. Pregabalin binds with high affinity and specificity to voltage-gated calcium channel alpha(2)-delta proteins. The putative mechanism of action of the drug is reduced excitatory neurotransmit...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.2165/00023210-200519030-00007
更新日期：2005-01-01 00:00:00
abstract：:Schizophrenia is a long-term psychiatric disorder that impacts important mental functions and requires indefinite treatment, as well as psychosocial and economic support. The introduction of chlorpromazine, the first antipsychotic, and the subsequent development of a long list of similar dopamine-blocking antipsychoti...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.1007/s40263-018-0588-3
更新日期：2019-01-01 00:00:00
abstract：:The eating disorders anorexia nervosa and bulimia nervosa present with comorbidity in a number of important areas, including depression, bipolar disorder, anxiety disorders (obsessive-compulsive disorder, panic disorder, social anxiety disorder and other phobias, and post-traumatic stress disorder) and substance abuse...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.2165/00023210-200620080-00004
更新日期：2006-01-01 00:00:00
abstract：OBJECTIVE:To assess the relationship between the sustained pain free (SPF) and adverse event (AE) rates associated with six oral serotonin 5-HT(1B/1D) receptor agonists (triptans) used for the treatment of acute migraine, employing data from a previous meta-analysis (that included almotriptan, eletriptan, naratriptan, ...
journal_title：CNS drugs
pub_type： 杂志文章
doi：10.2165/00023210-200721010-00006
更新日期：2007-01-01 00:00:00
abstract：:Existing drug delivery methods have not led to a significant increase in survival for patients with malignant primary brain tumors. While the combination of conventional therapies consisting of surgery, radiotherapy, and chemotherapy has improved survival for some types of brain tumors (e.g., WNT medulloblastoma), oth...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.1007/s40263-020-00766-w
更新日期：2020-11-01 00:00:00
abstract：:There have been significant developments in the understanding of depression in children and adolescents in the past few years, including an increased recognition that significant depressive illness occurs in this patient group. Pharmacological and psychotherapeutic treatments are used to manage depression in children ...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.2165/00023210-200620010-00001
更新日期：2006-01-01 00:00:00
abstract：BACKGROUND:Although levodopa is considered the most effective pharmacotherapy for motor symptoms of Parkinson's disease (PD), chronic use is associated with motor complications, including fluctuating response and unpredictable, involuntary movements called dyskinesia. ADS-5102 (amantadine) extended-release (ER) capsule...
journal_title：CNS drugs
pub_type： 杂志文章,随机对照试验
doi：10.1007/s40263-018-0498-4
更新日期：2018-04-01 00:00:00
abstract：:Female hypoactive sexual desire disorder (HSDD) may occur in up to one-third of adult women in the US. The essential feature of female HSDD is a deficiency or absence of sexual fantasies and desire for sexual activity that causes marked distress or interpersonal difficulty. The evaluation of female HSDD generally requ...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.2165/00023210-200216110-00003
更新日期：2002-01-01 00:00:00
abstract：:Spinal cord injury (SCI) has a number of severe and disabling consequences, including chronic pain, and around 40% of patients develop persistent neuropathic pain. Pain following SCI has a detrimental impact on the patient's quality of life and is a major specific healthcare problem in its own right. Thus far, there i...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.2165/00023210-200822060-00002
更新日期：2008-01-01 00:00:00
abstract：BACKGROUND:Diroximel fumarate (DRF) is a novel oral fumarate approved in the USA for relapsing forms of multiple sclerosis. DRF is converted to monomethyl fumarate, the pharmacologically active metabolite of dimethyl fumarate (DMF). DRF 462 mg and DMF 240 mg produce bioequivalent exposure of monomethyl fumarate and are...
journal_title：CNS drugs
pub_type： 杂志文章
doi：10.1007/s40263-020-00700-0
更新日期：2020-02-01 00:00:00
abstract：:The coronavirus 2019 (COVID-19) pandemic is expected to linger. Decisions regarding initiation or continuation of disease-modifying therapy for multiple sclerosis have to consider the potential relevance to the pandemic. Understanding the mechanism of action and the possible idiosyncratic effects of each therapeutic a...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.1007/s40263-020-00756-y
更新日期：2020-09-01 00:00:00
abstract：:Evidence-based treatment approaches for generalized anxiety disorder (GAD) comprise psychotherapy, pharmacotherapy, or a combination of the two. First-line pharmacotherapy agents include selective serotonin reuptake inhibitors, selective serotonin-norepinephrine reuptake inhibitors, and, in certain European guidelines...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.1007/s40263-014-0162-6
更新日期：2014-06-01 00:00:00
abstract：:Ursolic acid is a pentacyclic triterpenoid found in several plants. Despite its initial use as a pharmacologically inactive emulsifier in pharmaceutical, cosmetic and food industries, several biological activities have been reported for this compound so far, including anti-tumoural, anti-diabetic, cardioprotective and...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.1007/s40263-017-0474-4
更新日期：2017-12-01 00:00:00
abstract：:The original article can be found online. ...
journal_title：CNS drugs
pub_type： 杂志文章,已发布勘误
doi：10.1007/s40263-018-0561-1
更新日期：2018-09-01 00:00:00
abstract：:Epileptic encephalopathy is defined as a condition where the epileptic activity itself may contribute to the severe neurological and cognitive impairment seen, over and above that which would be expected from the underlying pathology alone. The epilepsy syndromes at high risk of this are a disparate group of condition...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.1007/s40263-013-0041-6
更新日期：2013-03-01 00:00:00
abstract：:Secondary progressive multiple sclerosis (SPMS) is diagnosed retrospectively and involves a clinical course characterized by a progressive accumulation of neurological disability, independent of relapses, following an initial relapsing-remitting (RR) phase. Our incomplete understanding of the pathological mechanisms u...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.1007/s40263-016-0340-9
更新日期：2016-06-01 00:00:00
abstract：UNLABELLED:Tianeptine is an antidepressant agent with a novel neurochemical profile. It increases serotonin (5-hydroxytryptamine; 5-HT) uptake in the brain (in contrast with most antidepressant agents) and reduces stress-induced atrophy of neuronal dendrites. Like the selective serotonin reuptake inhibitors (SSRIs) and...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.2165/00023210-200115030-00006
更新日期：2001-01-01 00:00:00
abstract：:Narcolepsy type 1 and narcolepsy type 2 are central disorders of hypersomnolence. Narcolepsy type 1 is characterized by excessive daytime sleepiness and cataplexy and is associated with hypocretin-1 deficiency. On the other hand, in narcolepsy type 2, cerebrospinal fluid hypocretin-1 levels are normal and cataplexy ab...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.1007/s40263-016-0337-4
更新日期：2016-05-01 00:00:00
abstract：INTRODUCTION:Valproic acid is a versatile antiepileptic drug that is often used in the acute care setting. Intravenous valproic acid lends itself well to a continuous infusion as it exhibits a relatively short half-life. We evaluated the pharmacokinetics and clinical efficacy of continuous infusion valproic acid in hos...
journal_title：CNS drugs
pub_type： 杂志文章
doi：10.1007/s40263-015-0304-5
更新日期：2016-01-01 00:00:00
